Categories: Videos

Indian Covid19 Vaccine Bharat Biotech’s Covaxin 93.4% Effective As Per Phase III Trials

<p>
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/R5A5c9huD3s" title="YouTube video player" width="560"></iframe></p>
<p>
<span style="color: rgb(13, 13, 13); font-family: Roboto, Noto, sans-serif; font-size: 15px; white-space: pre-wrap;">India made Bharat Biotech's Covaxin found to be "93.4 percent effective" against severe symptomatic COVID19 cases in Phase-III trials. Covaxin is overall 77.8 percent effective against Covid, the vaccine maker said today. It also offers "65.2 percent protection" against the rapidly emerging Delta Variant. Watch the full story to know more!</span></p>

IN Bureau

Recent Posts

Balochistan: Medical students protest campus closure, security crackdown

Students at the Bolan Medical College (BMC) in Balochistan's Quetta entered the 27th day of…

25 minutes ago

Climate change, health risks escalate amid surge in PoGB deforestation

The intensifying cutting of trees for firewood in Pakistan-occupied Gilgit-Baltistan (PoGB) is not only worsening…

2 hours ago

India’s retired judges, bureaucrats call for “immediate end” to attacks on minorities in open letter to Bangladesh

A group of retired judges, bureaucrats, Army officials and other civil society members have penned…

2 hours ago

Israel, Slovakia sign historic USD 582 million deal to boost Air Defense capabilities

Israel and Slovakia signed a 2 billion shekel (USD 582 million) agreement on Monday to…

2 hours ago

Pakistan: Protests continue in Kurram over road closures amid crisis

Protests against the prolonged road closures in Kurram persisted on Sunday, as residents held a…

3 hours ago

Sikyong Penpa Tsering successfully concludes key engagements in US, strengthening Tibetan cause

Sikyong Penpa Tsering, the political leader of the Central Tibetan Administration (CTA), has successfully concluded…

4 hours ago